Literature DB >> 15548781

Advances in H1-antihistamines.

F Estelle R Simons1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15548781     DOI: 10.1056/NEJMra033121

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  116 in total

1.  Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data.

Authors:  Deborah Layton; Vicki Osborne; Anna Gilchrist; Saad A W Shakir
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

2.  [Not Available].

Authors:  A Cheng
Journal:  Paediatr Child Health       Date:  2011-01       Impact factor: 2.253

3.  Antihistamine medication may alleviate negative effects of prenatal exposure to polycyclic aromatic hydrocarbons (PAH) on lung function in children. Birth cohort prospective study.

Authors:  Wieslaw A Jedrychowski; Frederica P Perera; Umberto Maugeri; Renata Majewska; Jack Spengler; Elzbieta Mroz; Elzbieta Flak; Maria Klimaszewska-Rembiasz; David Camman
Journal:  Pediatr Pulmonol       Date:  2014-08-22

4.  Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Andrew Boshier; Victoria Cornelius; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  H1-antihistamines for the treatment of anaphylaxis with and without shock.

Authors:  A Sheikh; V m ten Broek; S G A Brown; F E R Simons
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 6.  The safety and efficacy of desloratadine for the management of allergic disease.

Authors:  William E Berger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  [New generation antihistamines as monotherapy or in combination. What is the relevance for daily clinical routine for allergic rhinoconjunctivitis].

Authors:  R Mösges; J Köberlein
Journal:  HNO       Date:  2007-06       Impact factor: 1.284

8.  Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Effect of budesonide and azelastine on histamine signaling regulation in human nasal epithelial cells.

Authors:  Shao-Cheng Liu; Chun-Shu Lin; Shyi-Gen Chen; Yueng-Hsiang Chu; Fei-Peng Lee; Hsuan-Hsuan Lu; Hsing-Won Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-13       Impact factor: 2.503

10.  Toxicological identification of diphenhydramine (DPH) in suicide.

Authors:  Lena Eckes; Michael Tsokos; Sieglinde Herre; René Gapert; Sven Hartwig
Journal:  Forensic Sci Med Pathol       Date:  2012-10-12       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.